101 related articles for article (PubMed ID: 1158035)
1. Red cell 2, 3-diphosphoglycerate levels among diabetic patents with and without vascular complications.
Kanter Y; Bessman SP; Bessman A
Diabetes; 1975 Aug; 24(8):724-9. PubMed ID: 1158035
[TBL] [Abstract][Full Text] [Related]
2. Red cell 2,3-DPG levels in diabetic vasculopathy.
Puxeddu A; Brunetti P; Calabrese G; Scionti L; De Angelis M; Pentiricci N; Bolli G; Massi-Benedetti M
Acta Diabetol Lat; 1979; 16(4):311-5. PubMed ID: 550673
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of the 2,3-diphosphoglycerate content of erythrocytes in diabetes mellitus].
Bodnar PN; Pristupiuk AM
Probl Endokrinol (Mosk); 1982; 28(5):15-7. PubMed ID: 7145879
[TBL] [Abstract][Full Text] [Related]
4. [2,3-DPG and diabetic microangiopathy].
Faure Nogueras E; Millastre Benito A; Blasco Comenge MC; García Alvarez F; Gutiérrez Martín M
Rev Clin Esp; 1981 Nov; 163(4):227-30. PubMed ID: 7335930
[No Abstract] [Full Text] [Related]
5. Abnormal hemorheology in diabetes mellitus.
Barnes A; Locke P; Dormandy J; Dormandy T
Bibl Anat; 1977; (16 Pt 2):428-9. PubMed ID: 603576
[No Abstract] [Full Text] [Related]
6. [Erythrocytic 2-3-diphosphoglycerate in diabetes mellitus].
Giardina E; Triolo G; Contorno A; Rinaldi A
Minerva Med; 1980 Jun; 71(24):1731-4. PubMed ID: 7413105
[TBL] [Abstract][Full Text] [Related]
7. Oxygen transport impairment in diabetes.
Ditzel J
Diabetes; 1976; 25(2 SUPPL):832-8. PubMed ID: 9322
[TBL] [Abstract][Full Text] [Related]
8. Oxygen affinity of hemoglobin and peripheral nerve degeneration in experimental diabetes.
Farber SD; Farber MO; Brewer G; Magnes CJ; Peterson RG
J Neurol Sci; 1991 Feb; 101(2):204-7. PubMed ID: 2033405
[TBL] [Abstract][Full Text] [Related]
9. [Quality of blood sugar control and late complications of diabetes].
Sélam JL
Rev Med Suisse Romande; 1995 Sep; 115(9):653-7. PubMed ID: 7481350
[No Abstract] [Full Text] [Related]
10. Red cell filterability and metabolic state in diabetic subjects with macro-angiopathy.
Le Devehat C; Lemoine A; Cirette B; Ramet M
Scand J Clin Lab Invest Suppl; 1981; 156():155-8. PubMed ID: 6948378
[TBL] [Abstract][Full Text] [Related]
11. The problems of tissue oxygenation in diabetes mellitus. III. The "three-in-one concept" for the development of diabetic microangiopathy and a rational approach to its prophylaxis.
Ditzel J
Acta Med Scand Suppl; 1975; 578():69-83. PubMed ID: 1057374
[TBL] [Abstract][Full Text] [Related]
12. 2,3-diphosphoglycerate, nucleotide phosophate, and organic and inorganic phosphate levels during the early phases of diabetic ketoacidosis.
Kanter Y; Gerson JR; Bessman AN
Diabetes; 1977 May; 26(5):429-33. PubMed ID: 15918
[TBL] [Abstract][Full Text] [Related]
13. The problem of tissue oxygenation in diabetes mellitus.
Ditzel J; Standl E
Acta Med Scand Suppl; 1975; 578():59-68. PubMed ID: 239528
[TBL] [Abstract][Full Text] [Related]
14. [Relation between glycohemoglobin, hypoxia parameters and diabetic microangiopathy].
Gräfenstein K; Duchna W
Z Gesamte Inn Med; 1985 Apr; 40(8):229-31. PubMed ID: 4013438
[TBL] [Abstract][Full Text] [Related]
15. [Relation between 2,3-DPG changes and venous blood gas in diabetic patients with peripheral neuropathy].
Zhou ZG
Zhonghua Yi Xue Za Zhi; 1987 Oct; 67(10):536-8, 32. PubMed ID: 3127004
[No Abstract] [Full Text] [Related]
16. Letter: Increased haemoglobin A1c and 2,3-diphosphoglycerate in diabetes and their effects on red-cell oxygen-releasing capacity.
Ditzel J; Andersen H; Peters ND
Lancet; 1973 Nov; 302(7836):1034. PubMed ID: 4127262
[No Abstract] [Full Text] [Related]
17. Diabetic regulation and its relationship to microangiopathy.
Raskin P
Metabolism; 1978 Feb; 27(2):235-52. PubMed ID: 340847
[TBL] [Abstract][Full Text] [Related]
18. Reduced tissue oxygenation and its reversibility by glycemic control in diabetic patients.
Iino K; Yoshinari M; Doi Y; Shinohara N; Iwase M; Fujishima M
Diabetes Res Clin Pract; 1997 Jan; 34(3):163-8. PubMed ID: 9069568
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term training and acute physical exercise on red cell 2,3-diphosphoglycerate.
Remes K; Vuopio P; Härkönen M
Eur J Appl Physiol Occup Physiol; 1979 Nov; 42(3):199-207. PubMed ID: 527581
[TBL] [Abstract][Full Text] [Related]
20. Is hyperviscosity a treatable component of diabetic microcirculatory disease?
Barnes AJ; Locke P; Scudder PR; Dormandy TL; Dormandy JA; Slack J
Lancet; 1977 Oct; 2(8042):789-91. PubMed ID: 71601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
